Detalhe da pesquisa
1.
Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.
Breast Cancer Res Treat
; 148(2): 437-44, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25257728
2.
Ki-67 Testing in Breast Cancer: Assessing Variability With Scoring Methods and Specimen Types and the Potential Subsequent Impact on Therapy Eligibility.
Appl Immunohistochem Mol Morphol
; 32(3): 119-124, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450704
3.
Communication with physicians and family about breast Cancer recurrence.
PEC Innov
; 3: 100237, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148854
4.
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.
Ther Adv Med Oncol
; 15: 17588359231217976, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152697
5.
Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical Study.
PLoS One
; 10(4): e0124988, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25909710
6.
A Narrative Review of the Confluence of Breast Cancer and Low-wage Employment and Its Impact on Receipt of Guideline-recommended Treatment.
Glob Adv Health Med
; 2(5): 75-85, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24416698
7.
Iron deficiency anemia.
Am Fam Physician
; 75(5): 671-8, 2007 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17375513